None
Quote | NovaBay Pharmaceuticals Inc. (NYSE:NBY)
Last: | $0.0788 |
---|---|
Change Percent: | -0.13% |
Open: | $0.0771 |
Close: | $0.0788 |
High: | $0.087 |
Low: | $0.077 |
Volume: | 2,478,498 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | NovaBay Pharmaceuticals Inc. (NYSE:NBY)
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces a new and enhanced marketing program that includes text message communications (SMS) and targeted email programs aimed at enhancing the...
2024-04-22 01:43:28 ET More on NovaBay NovaBay Pharmaceuticals show 13% rise in eyecare and wound care segment - prelim report Seeking Alpha’s Quant Rating on NovaBay Historical earnings data for NovaBay Read the full article on Seeking Alpha F...
Message Board Posts | NovaBay Pharmaceuticals Inc. (NYSE:NBY)
Subject | By | Source | When |
---|---|---|---|
What do you make of this? | Trofee | investorshub | 06/20/2023 1:02:22 PM |
$NBY The trading | roberttatge | investorshub | 04/21/2023 9:26:29 AM |
$NBY best news of the day | roberttatge | investorshub | 04/20/2023 9:05:00 AM |
Price trading | Trofee | investorshub | 04/11/2023 5:56:29 PM |
$NBY short squeeze all day | Silver Paddy | investorshub | 04/08/2023 6:51:21 AM |
News, Short Squeeze, Breakout and More Instantly...
NovaBay Pharmaceuticals Inc. Company Name:
NBY Stock Symbol:
NYSE Market:
NovaBay Pharmaceuticals Inc. Website:
NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces a new and enhanced marketing program that includes text message communications (SMS) and targeted email programs aimed at enhancing the...
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE American continued listing standards set forth in Sections 1003(a)(ii) and (iii) of the NYSE...
Growth driven by efficient Avenova ® direct-to-consumer e-marketing programs NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) reports preliminary net revenue for its eyecare and wound care business for the first quarter of 2024 of $2.6 million, a 13% increase ...